StockNews.AI · 2 days
Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc.
Original sourceSI-BONE, Inc. reported a robust Q4 2025, with 15% revenue growth and positive adjusted EBITDA of $5.1 million, reflecting operational improvements. The company’s strategic partnership with Smith+Nephew and favorable market conditions position it for continued growth, with 2026 revenue guidance indicating an increase of up to 16%.
SIBN's significant revenue growth and improved metrics suggest positive market reception, reminiscent of past performance surges after similar announcements.
Investors should consider SIBN as a buy for growth potential in the next 12 months.
This falls under Corporate Developments as SIBN's strategic partnership and financial results indicate strong potential for further business expansion and effective market positioning amidst growing demand for its products.